Onsdag 28 Oktober | 21:12:26 Europe / Stockholm
Est. tid*
2027-11-23 07:10 Kvartalsrapport 2027-Q3
2027-08-25 07:10 Kvartalsrapport 2027-Q2
2027-05-26 07:10 Kvartalsrapport 2027-Q1
2027-03-16 N/A Årsstämma
2027-02-24 07:05 Bokslutskommuniké 2026
2026-11-26 07:10 Kvartalsrapport 2026-Q3
2026-08-25 - Kvartalsrapport 2026-Q2
2026-05-27 - Kvartalsrapport 2026-Q1
2026-03-26 - X-dag ordinarie utdelning FLUO 0.00 DKK
2026-03-25 - Årsstämma
2026-02-25 - Bokslutskommuniké 2025
2025-11-27 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-28 - Kvartalsrapport 2025-Q1
2025-03-28 - X-dag ordinarie utdelning FLUO 0.00 DKK
2025-03-27 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-11-27 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-30 - Kvartalsrapport 2024-Q1
2024-03-21 - X-dag ordinarie utdelning FLUO 0.00 DKK
2024-03-20 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-29 - Kvartalsrapport 2023-Q3
2023-08-30 - Kvartalsrapport 2023-Q2
2023-05-31 - Kvartalsrapport 2023-Q1
2023-03-22 - X-dag ordinarie utdelning FLUO 0.00 DKK
2023-03-21 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-31 - Kvartalsrapport 2022-Q1
2022-05-19 - X-dag ordinarie utdelning FLUO 0.00 DKK
2022-05-18 - Årsstämma
2022-03-30 - Bokslutskommuniké 2021
2021-11-24 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-05-26 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning FLUO 0.00 DKK
2021-02-26 - Bokslutskommuniké 2020
2021-02-09 - Årsstämma
2020-11-20 - Kvartalsrapport 2020-Q3
2020-08-14 - Kvartalsrapport 2020-Q2
2020-05-27 - Kvartalsrapport 2020-Q1
2020-04-09 - X-dag ordinarie utdelning FLUO 0.00 DKK
2020-04-08 - Årsstämma
2020-02-28 - Bokslutskommuniké 2019
2019-11-29 - Kvartalsrapport 2019-Q3
2019-05-31 - Kvartalsrapport 2019-Q1
LandDanmark
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
FluoGuide är ett danskt bolag verksamt inom medicinteknik. Bolaget affärsfokus återfinns inom forskning och utveckling av behandlingar av olika cancerformer, med störst fokus på utveckling av produkter som vägleder vid kirurgiska ingrepp. Produkterna binder till sig cancercellerna som då lyser upp och är avsedda att användas för att med precision kunna ta bort skadliga tumörer i patientens vävnad.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Communiqué from extraordinary general meeting in FluoGuide A/S

2020-02-17 14:21:36
FluoGuide A/S (“FluoGuide” or “the Company”) held today an Extraordinary General Meeting (“EGM”). The resolution on a directed issue was resolved.

Item 1: Authorisation to the board of directors to increase the share capital at market price or at a rate discounted to the market price without pre-emption rights for existing shareholders

The board of directors of the Company has, subject to authorization from the general meeting, decided to conduct a directed share issue of approx. MDKK 11.6 (before issue costs of approx. MDKK 0.5). Participants in the directed share issue are, amongst others, the institutional investors A/S Arbejdernes Landsbank and Linc AB, a Swedish based life science investor with a long list of successful investments.

The EGM decided to increase the existing authorisation to the board of directors in article 3.2.2 of the articles of association to increase the Company’s share capital in one or more issues of new shares without pre-emption rights for the Company’s existing shareholders by up to nominally DKK 223,099.40 from previously nominally DKK 81,000.00. According to the existing authorisation the capital increase shall be made at market price. The subscription price for the contemplated issue of shares is DKK 5.20 per share which corresponds to the market-based price determined by the board of directors based on a twenty-day average volume-weighted price for the Company's shares prior to the board of directors’ decision to conduct a directed share issue with a discount of approx. 10 percent. In order to take account for the discount to the market price, it was decided to amend the existing authorisation to the effect that the authorisation also allows for capital increases at a rate discounted to the market price. The capital increase shall take place by way of cash contribution.

The adoption of the proposal resulted in an updated clause 3.2.2 of the articles of association of the Company with the following wording:

  • 3.2.2 (Danish): Bestyrelsen er i perioden fra den 17. februar 2020 og indtil den 30. juni 2020 bemyndiget til uden fortegningsret for Selskabets eksisterende aktionærer at forhøje Selskabets aktiekapital ad én eller flere gange med i alt op til nominelt DKK 223.099,40. Kapitalforhøjelsen skal ske til markedskurs eller med en rabat i forhold til markedskursen. Kapitalforhøjelsen skal ske ved kontant indbetaling.
  • 3.2.2 (English): In the period from 17 February 2020 and until 30 June 2020, the board of directors is authorised to increase the Company’s share capital in one or more issues of new shares without pre-emption rights for the Company’s existing shareholders by up to a nominal amount of DKK 223,099.40. The capital increase shall take place at market price or at a rate discounted to the market price. The capital increase shall take place by way of cash contribution.

As VP Investor Services A/S has changed the name to VP Services A/S, it was decided that clauses 2.5, 5.9, 5.11 of the articles of association are changed accordingly.

 

Item 2: Documents for the general meeting shall in the future only be prepared in English

The EGM decided that in the future documents prepared for the general meeting shall be prepared in English only, ref. section 110(6) of the Danish Companies Act.

 

The resolutions from the extraordinary general meeting were adopted unanimously.

Copenhagen, 17 February 2020

FluoGuide A/S
The board of directors